🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Viewers are urged to message these profiles directly for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Additionally, a robust trade exists on Telegram, where communities with thousands of members share comparison images, injection guides and claims of rapid UK delivery. Vendors market the drug there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in users injecting substances of unknown origin.

Several professionals said the popularity for the experimental drug could be linked to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Several influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, risking fines, legal action or prison.

Platform Reaction and Material Removal

Based on TikTok, the platform has taken down problematic content and prohibited related hashtags and query recommendations. The organization stated it was dedicated to maintaining the service secure and allocating resources in enhancing enforcement strategies.

Online Trading Activities

Investigations also found groups with up to 9,000 participants marketing the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with numerous of members, populated with photos of weight loss, glowing reviews and step-by-step guides for preparing or administering at residence.

After minutes of joining one group, a vendor shared WhatsApp details, where most transactions occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about weight, health issues or past usage.

Item Details and Costs

Inside these groups, posts show dark colored packages with Royal Mail labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how long a pen should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service stated it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has previously seen patients harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject users to potentially significant health risks”.